Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 17/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6724365 | 0.91 | TLR7 (0.43) | TLR7 | |
| SCHEMBL6095413 | 0.84 | TLR7 (0.40) | TLR7 | |
| SCHEMBL3353948 | 0.81 | TLR7 (0.46) | TLR7 | |
| SCHEMBL6093743 | 0.75 | TLR7 (0.50) | TLR7 | |
| SCHEMBL6097280 | 0.73 | TLR7 (0.55) | TLR7 | |
| SCHEMBL4793756 | 0.70 | SMN1; SMN2 (0.47) | TLR7 | |
| SCHEMBL6726102 | 0.70 | TLR7 (0.49) | TLR7 | |
| SCHEMBL4875215 | 0.69 | TLR7 (0.39) | TLR7 | |
| SCHEMBL4792366 | 0.67 | HPGD (0.39) | TLR7 | |
| SCHEMBL4794750 | 0.66 | HPGD (0.39) | TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040019076-A1 | SULFONAMIDO SUBSTITUTED IMIDAZOPYRIDINES | 3M INNOVATIVE PROPERTIES COMPANY | 2004-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019076-A1 | SULFONAMIDO SUBSTITUTED IMIDAZOPYRIDINES | IRF3, EIF2AK2, MYD88 | TLR7 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.